1 Safe-and-Steady Stock on Our Buy List and 2 Facing Headwinds
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Finding the right balance between safety and returns isn’t easy, which is why StockStory is here to help. That said, here is one low-volatility stock providing safe-and-steady growth and two that may not deliver the returns you need.
Two Stocks to Sell:
Edgewell Personal Care (EPC)
Rolling One-Year Beta: -0.14
Boasting brands such as Banana Boat, Schick, and Skintimate, Edgewell Personal Care (NYSE:EPC) sells personal care products in the skin and sun care, shave, and feminine care categories.
Why Do We Think EPC Will Underperform?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Operating margin declined by 6.8 percentage points over the last year as its sales cratered
- Earnings per share decreased by more than its revenue over the last three years, showing each sale was less profitable
Edgewell Personal Care’s stock price of $27.73 implies a valuation ratio of 11.8x forward P/E. Read our free research report to see why you should think twice about including EPC in your portfolio.
Strategic Education (STRA)
Rolling One-Year Beta: 0.50
Formed through the merger of Strayer Education and Capella Education in 2018, Strategic Education (NASDAQ:STRA) is a career-focused higher education provider.
Why Should You Sell STRA?
- Demand for its offerings was relatively low as its number of domestic students has underwhelmed
- Earnings growth over the last five years fell short of the peer group average as its EPS only increased by 3% annually
- Free cash flow margin is expected to remain in place over the coming year
Strategic Education is trading at $82.41 per share, or 9.9x forward P/E. To fully understand why you should be careful with STRA, check out our full research report (it’s free).
One Stock to Buy:
IMAX (IMAX)
Rolling One-Year Beta: 0.27
Originally developed for World Expo '67 in Montreal as an innovative projection system, IMAX (NYSE:IMAX) provides proprietary large-format cinema technology and systems that deliver immersive movie experiences with enhanced image quality and sound.
Why Will IMAX Outperform?
- Impressive 17.9% annual revenue growth over the last five years indicates it’s winning market share this cycle
- Free cash flow margin increased by 24.8 percentage points over the last five years, giving the company more capital to invest or return to shareholders
- Historical investments are beginning to pay off as its returns on capital are growing
At $51.21 per share, IMAX trades at 22.1x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.